Pharmaceutical Networks: The Political Economy of Drug Development in the United States, 1945–1980
研究了二战后三十年里美国制药公司、生物医学研究者、医生和国会改革者如何共同塑造处方药的研究、监管和政策环境，以及制药业如何通过联盟应对改革运动。
Pharmaceutical Networks describes how American drug firms,biomedical researchers, physicians, and Congressional reformers shaped the research, regulatory, and policy environments for prescription drugs in the three decades after World War II. In these decades, pharmaceutical reformers in Congress sought to secure passage of legislation that would increase the government's control over drug development, distribution, and practice. They proposed these reforms as a way of curbing the high cost of prescription drugs and putting a break on the escalating health care costs. To defend itself against this reform movement, the American drug industry built alliances with research universities, medical schools, and professional medical societies by offering to the medical and academic communities solutions to their shared problems. These problems included a shortage of biomedical workers and the increasing authority of the government over medical practice.